MedTrace Logo

Development of Online Store for Testing Regulatory Food and Nutrition Policies in Brazil

NCT05789238 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3026

Last updated 2023-07-03

No results posted yet for this study

Summary

The purpose of this randomized controlled trial is to assess the impact of different nutrient profiles for magnifying glass front-of-package labels (FOPLs) on consumer choices in an online grocery store. Participants will be adults residing in Brazil recruited through a survey research firm. Participants will be randomly assigned to one of three shopping environments in an online grocery store. Participants will complete a shopping task (selecting items from a pre-specified shopping list) in the online grocery store. After completing the shopping task, participants will be rerouted to a computer survey. The survey will include standard behavior and label perception questions, as well as demographic items.

Conditions

  • Dietary Habits

Interventions

BEHAVIORAL

ANVISA

Products carrying front-of-package labels based on Brazil's Health Regulatory Agency (ANVISA's) nutrient profile model

BEHAVIORAL

PAHO

Products carrying front-of-package labels based on the Pan-American Health Organization (PAHO's) nutrient profile model

Sponsors & Collaborators

  • University of Campinas, Brazil

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Ana Clara Duran, PhD · University of Campinas

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-24
Primary Completion
2023-06-28
Completion
2023-06-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05789238 on ClinicalTrials.gov